Impact of Development on Protein Utilization and Growth

发育对蛋白质利用和生长的影响

基本信息

  • 批准号:
    6681772
  • 负责人:
  • 金额:
    $ 33.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Despite improvements in nutritional management of low birth weight (LBW) infants over the past decade, most who weigh <1500g at birth, even if appropriate size for gestational age at birth, weigh less than and are shorter than the 10th percentiles of intrauterine standards at discharge (approximately 36 wks post menstrual age) and many remain small as late as adolescence and young adulthood. While the consequences of the early growth failure are not known with certainty, there is evidence that it may contribute to the high prevalence of developmental deficits in this population. Studies are proposed to test the hypothesis that there is a finite period during which the human infant is capable of maximal utilization of protein for growth. Based on limited studies in infants and acute studies in animals, this period appears to encompass the latter part of gestation and the first few months post-term but it remains undefined. Corollary hypotheses, which also will be tested in human infants, are that maximizing protein intake during this finite period of enhanced sensitivity to protein intake will improve growth and, hence, reduce the subsequent growth and neurodevelopmental deficits of preterm infants. In toto, the proposed studies will determine if there is a finite period during which the human neonate can maximally utilize protein intake for growth as measured by whole body protein turnover and also will define this period. They also will determine if maximizing protein intake during this finite period improves early growth without imposing unacceptable metabolic consequences and if this improved growth reduces subsequent growth and neurodevelopmental deficits. Overall, the findings of this project are expected to contribute to further improvements in nutritional management and, hence, outcome of LBW infants.
描述(申请人提供):尽管低出生体重(LBW)婴儿的营养管理在过去十年中有所改善,但大多数出生时体重为1500克的婴儿,即使出生时的大小适合胎龄,在出院时(大约月经后36周)体重也低于或低于宫内标准的10%,而且许多人直到青春期和成年期都很小。虽然早期增长失败的后果尚不确定,但有证据表明,它可能导致这一人群中发育缺陷的高发。有人建议进行研究,以检验这一假设,即在有限的时期内,人类婴儿能够最大限度地利用蛋白质进行生长。根据对婴儿的有限研究和对动物的急性研究,这一时期似乎包括怀孕的后期和足月后的头几个月,但它仍然没有定义。也将在人类婴儿身上测试的推论是,在对蛋白质摄取的敏感度增强的有限时期内,最大限度地摄取蛋白质将促进生长,从而减少早产儿随后的生长和神经发育缺陷。总之,拟议的研究将确定是否存在一个有限的时期,在此期间,人类新生儿可以最大限度地利用蛋白质摄入量来促进生长,这是通过全身蛋白质周转来衡量的,并将定义这一时期。他们还将确定在这段有限的时间内最大限度地摄入蛋白质是否在不造成不可接受的代谢后果的情况下改善早期生长,以及这种改善的生长是否减少了随后的生长和神经发育缺陷。总体而言,预计该项目的结果将有助于进一步改善营养管理,从而有助于改善LBW婴儿的结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William C. Heird其他文献

Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic &lt;span class="small-caps"&gt;L&lt;/span&gt;-amino acids: A preliminary report
  • DOI:
    10.1016/s0022-3476(72)80396-2
  • 发表时间:
    1972-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    William C. Heird;John F. Nicholson;John M. Driscoll;John N. Schullinger;Robert W. Winters
  • 通讯作者:
    Robert W. Winters
Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa
  • DOI:
    10.1016/s0022-2275(20)30271-6
  • 发表时间:
    2001-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dennis R. Hoffman;James C. DeMar;William C. Heird;David G. Birch;Robert E. Anderson
  • 通讯作者:
    Robert E. Anderson
Improved methods of non-oral neonatal feeding: A commentary
  • DOI:
    10.1016/s0022-3476(73)80425-1
  • 发表时间:
    1973-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    William C. Heird
  • 通讯作者:
    William C. Heird
Effect of Quantity of Concomitant Energy (E) Intake of Low Birth Weight (LBW) Infants on Leucine Oxidation † 1388
  • DOI:
    10.1203/00006450-199704001-01407
  • 发表时间:
    1997-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Sudha Kashyap;Kyoko Okira-Kist;William W. Wong;Farook Jahoor;William C. Heird
  • 通讯作者:
    William C. Heird

William C. Heird的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William C. Heird', 18)}}的其他基金

IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    8356656
  • 财政年份:
    2010
  • 资助金额:
    $ 33.86万
  • 项目类别:
IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    8166655
  • 财政年份:
    2009
  • 资助金额:
    $ 33.86万
  • 项目类别:
IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    7950591
  • 财政年份:
    2008
  • 资助金额:
    $ 33.86万
  • 项目类别:
IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    7605857
  • 财政年份:
    2007
  • 资助金额:
    $ 33.86万
  • 项目类别:
COMPARISON OF TWO METHODS FOR STUDYING PROTEIN METABOLISM IN HEALTHY ADULTS
研究健康成人蛋白质代谢的两种方法的比较
  • 批准号:
    7375048
  • 财政年份:
    2005
  • 资助金额:
    $ 33.86万
  • 项目类别:
IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    7374969
  • 财政年份:
    2005
  • 资助金额:
    $ 33.86万
  • 项目类别:
IMPACT OF DEVELOPMENT ON PROTEIN UTILIZATION AND GROWTH
发育对蛋白质利用和生长的影响
  • 批准号:
    7206773
  • 财政年份:
    2004
  • 资助金额:
    $ 33.86万
  • 项目类别:
Impact of Development on Protein Utilization and Growth
发育对蛋白质利用和生长的影响
  • 批准号:
    6785926
  • 财政年份:
    2003
  • 资助金额:
    $ 33.86万
  • 项目类别:
Impact of Development on Protein Utilization and Growth
发育对蛋白质利用和生长的影响
  • 批准号:
    6920814
  • 财政年份:
    2003
  • 资助金额:
    $ 33.86万
  • 项目类别:
Impact of Development on Protein Utilization and Growth
发育对蛋白质利用和生长的影响
  • 批准号:
    7270065
  • 财政年份:
    2003
  • 资助金额:
    $ 33.86万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.86万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 33.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了